Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Typically $180,000 USD total over 2 years (paid in annual installments; amounts may vary by region)
Summary: Supports innovative research by emerging investigators, with a focus on diversity and health inequities in HIV, viral hepatitis, liver disease, and oncology.
Key Information: Forecasted cycle—dates and details subject to change; check program site for updates.